Skip to Main Content

Last September, Aegerion Pharmaceuticals (AEGR) agreed to pay $40 million to settle civil and criminal charges of illegally marketing a pricey cholesterol medicine, failing to adhere to a regulatory safety program, and misleading investors.

The settlement stemmed from a whistleblower lawsuit filed by three former employees, including Tricia Mullins, who last June had already taken a position with Horizon Pharma (HZNP). But a few weeks after the Aegerion deal was announced, Mullins lost her new job.

advertisement

Why? The company claimed she disclosed confidential information, but Mullins argued she was wrongfully terminated from her new job because of her role as a whistleblower in the Aegerion case, according to a lawsuit she filed last week in federal court in California.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

To submit a correction request, please visit our Contact Us page.